A Real-world Prospective Observational Study on the Efficacy and Safety of L-AmB(Liposomal Amphotericin B) for br- IFD(Breakthrough Invasive Fungal Disease) in Children and Adolescent Patients With Hematological Malignancies Receiving Triazoles or Echinocandins Prophylaxis
Clinical trial NCT07357038 · RECRUITING
Trial details
- NCT number
- NCT07357038
- Sponsor
- Institute of Hematology & Blood Diseases Hospital, China
- Status
- RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2025-09-30
- Primary completion
- 2027-02-28
- Enrollment
- 38
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.